Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 802153, 6 pages
Research Article

iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma

Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

Received 27 October 2014; Revised 14 February 2015; Accepted 2 March 2015

Academic Editor: Haifeng Yang

Copyright © 2015 Yushi Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Clizia Chinello, Vincenzo L’imperio, Martina Stella, Andrew James Smith, Giorgio Bovo, Angelica Grasso, Marco Grasso, Francesca Raimondo, Marina Pitto, Fabio Pagni, and Fulvio Magni, “The proteomic landscape of renal tumors,” Expert Review of Proteomics, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Robert Moulder, Santosh D. Bhosale, David R. Goodlett, and Riitta Lahesmaa, “Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling,” Mass Spectrometry Reviews, 2017. View at Publisher · View at Google Scholar
  • Qing Kay Li, Christian P. Pavlovich, Hui Zhang, Christopher R. Kinsinger, and Daniel W. Chan, “Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers,” Seminars in Cancer Biology, vol. 55, pp. 8–15, 2019. View at Publisher · View at Google Scholar